… to address key aspects of dengue's biology, many of which will play a crucial role for the
success of future control programmes, including vaccination. Within a multiscale perspective on …

… Despite formidable challenges in developing dengue vaccines, remarkable progression
towards … There have been several dengue vaccine candidates under development including live …

… an important theoretical challenge for the development of safe and effective dengue
vaccines. … Considerable progress is being made in DENV vaccine strategies. The first DENV …

… of a dengue vaccine is to achieve protection against the four serotypes. One dengue
vaccine was recently licensed (3), but phase 4 studies revealed that vaccination of DENV …

… Here we summarize the recent progress in the development of dengue vaccines … dengue
vaccines, we propose that prospective vaccine development should combine novel vaccine …

… for a dengue vaccine as a long-term protective approach. Despite there are numerous
vaccine candidates ahead, they could be held back by different aspects in promoting vaccine …

… vaccines are in advanced phase of clinical development, triggering expectation that a dengue
vaccine … efficacy in humans have made dengue vaccine development a challenging task. …

… Similarly to yellow fever, dengue is caused by viruses of the … had a vaccine for more than
80 years, the first dengue vaccine is only … how quickly dengue vaccines continue to progress. …

… Although one vaccine (Dengvaxia®) has been registered and … The challenge in dengue
vaccine development arises from … a dengue vaccine: progress and future challenges. Ann NY …

… , attenuated, and tetravalent recombinant vaccine called ChimeriVax™, … -dengue—tetravalent
dengue vaccine)—here, vaccine's names will be used according to the history of vaccine …